The pharmaceutical industry's pursuit of advanced antiviral solutions has positioned the Herpes Simplex Treatment Market as a focal point for innovation and investment. With herpes simplex virus affecting over 3.7 billion people globally, the demand for improved therapeutic interventions continues to drive substantial research and development initiatives across the...

The Herpes Simplex Virus (HSV) represents one of the most pervasive and chronic viral infections affecting populations globally. Categorized into two distinct types—HSV-1 and HSV-2—this pathogen exhibits multiple clinical presentations ranging from oral and genital lesions to complex neurological manifestations including encephalitis. The rising prevalence of HSV infections has...